BIAFEarnings•businesswire•
bioAffinity Technologies Reports Second Quarter 2025 Results
Sentiment:Positive (70)
Summary
SAN ANTONIO--(BUSINESS WIRE)-- #BIAF--bioAffinity Technologies reports Q2 2025 results; CyPath Lung revenues up 62% year-over-year in first six months of 2025
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on August 14, 2025 by businesswire